Catalyst Wire Dossier Catalyst Wire Dossier

Bemotrizinol 6%

bemotrizinol · dsm-firmenich Switzerland AG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Bemotrizinol 6%, covering 2023-02-22 to 2023-02-22. Get the full timeline:

Most recent: Clinical Trial Update: Pharmacokinetic (PK) Evaluation of Bemotrizinol (6%) in a Sunscreen Maximum Usage Trial [Phase 3]

See pricing